IWC
IRWD icon

Integrated Wealth Concepts’s Ironwood Pharmaceuticals IRWD Stock Holding History

Integrated Wealth Concepts’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$100K Buy
28,572
+17,136
+150% +$70.2K ﹤0.01% 2176
2025
Q4 		$38.5K Sell
11,436
-7,859
-41% -$20.4K ﹤0.01% 1584
2025
Q3 		$25.3K Buy
19,295
+3,406
+21% +$3.52K ﹤0.01% 1967
2025
Q2 		$11.4K Buy
+15,889
New +$12.5K ﹤0.01% 1896

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Integrated Wealth Concepts's IRWD Position: Q1 2026 in Review

Integrated Wealth Concepts increased its Ironwood Pharmaceuticals (IRWD) stake by 150% in Q1 2026, buying an estimated $70.2K and bringing the position to 28,572 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #2176.

Integrated Wealth Concepts first reported a position in IRWD in Q2 2025 and has held it in 4 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Integrated Wealth Concepts held 28,572 shares of Ironwood Pharmaceuticals worth $100K as of Q1 2026.
  • Integrated Wealth Concepts bought 17,136 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $70.2K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q1 2026, its #2176 holding.
  • Integrated Wealth Concepts first reported a position in Ironwood Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.